Skip to content

A study on the difference in the minimum alveolar effective concentration of sevoflurane between MCI and patients with sleep disorders caused by MCI

A study on the difference in the minimum alveolar effective concentration of sevoflurane between MCI and patients with sleep disorders caused by MCI

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082114
Enrollment
Unknown
Registered
2024-03-21
Start date
2022-01-16
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild cognitive impairment

Interventions

Normal patients:The initial concentration of sevoflurane at the end of breath is set to 2%. When the concentration reaches the set value and stabilizes for at least 15 minutes, skin cutting begins. If
If there is a positive body movement reaction, the end expiratory concentration of sevoflurane in the next patient will be increased by 0.2%
The midpoint from the patients negative reaction to the positive reaction is marked as the equilibrium point, and the experiment in this group ends at 7 equilibrium points.
mild cognitive impairment patients:The initial concentration of sevoflurane at the end of breath is set to 2%. When the concentration reaches the set value and stabilizes for at least 15 minutes, skin
mild cognitive impairment patients with sleep disorders :The initial concentration of sevoflurane at the end of breath is set to 2%. When the concentration reaches the set value and stabilizes for a
If there is a positive body movement reaction, the end expiratory conc

Sponsors

Cangzhou Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
60 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 60-75 years with body mass index (BMI) of 18.5-23.9 kg/m ~ 2, ASAI/II, without visual and hearing impairment were selected for breast cancer surgery under general anesthesia in our hospital.

Exclusion criteria

Exclusion criteria: Long-term use of analgesics; mental or neurological abnormalities, recent use of anesthesia and psychotropic drugs; liver and kidney dysfunction; alcohol and drug dependence; anemia, electrolyte disorders.

Design outcomes

Primary

MeasureTime frame
Kinesthetic reaction;

Secondary

MeasureTime frame
Heart rate;Mean Arterial Pressure;Intraoperative awareness rate;Plasma orexin-A;

Countries

China

Contacts

Public ContactWang Lei

Cangzhou Central Hospital

1058089565@qq.com+86 157 3170 1656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026